Home > Healthcare > Medical Devices > Diagnostic Devices > Self-monitoring Blood Glucose Devices Market

Self-monitoring Blood Glucose Devices Market Trends

Report ID: GMI2743
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Self-monitoring Blood Glucose Devices Market Trends

The self-monitoring blood glucose (SMBG) devices market is witnessing substantial growth, driven by the rising global prevalence of diabetes, technological advancements, and increasing awareness of the importance of regular blood glucose monitoring.
A key market trend is the integration of SMBG devices with digital health platforms and mobile applications, facilitating seamless tracking, analysis, and sharing of glucose data.
Moreover, the development of advanced glucose monitoring (CGM) systems, which offer real-time glucose readings and minimize the need for frequent finger pricks, is gaining significant traction. The demand for user-friendly and minimally invasive devices is further fueling innovation in the market.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global self-monitoring blood glucose devices delivery industry was valued at USD 10 billion in 2023 and is anticipated to register 11.6% CAGR between 2024 and 2032, driven by government initiatives for increasing awareness among people.

The market share from the consumables segment accounted USD 6.1 billion in 2023, owing to the increasing awareness of the importance of regular blood glucose monitoring and ongoing technological advancements.

North America self-monitoring blood glucose devices market was valued at USD 3.8 billion in 2023, owing to the high prevalence of diabetes and increasing technological advancements.

Abbott Laboratories, AgaMatrix, All Medicus Co., Ltd., Arkray, Inc., Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Bionime Corporation, DarioHealth Corp., and Dexcom, Inc.